Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Data exclusivity – a threat to generic manufacturing companies

  • At: 2009 FIP Congress in Istanbul (Turkey)
  • Type: Poster
  • By: KAMAREDDY, Sumalatha (Manipal Institute of Pharmaceutical Sciences, Manipal, India)
  • Co-author(s): Vijaya, Dwaraka (Manipal Institute of Pharmaceutical Sciences, MANIPAL, India)
    Reddy, Dileep (Matrix, HYDERABAD, India)
    Namala, Praveen kumar (Manipal Institute of Pharmaceutical Sciences, MANIPAL, India)
    Janodia, Manthan (Manipal Institute of Pharmaceutical Sciences, MANIPAL, India)
    Dharmagadda, Sreedhar (Manipal Institute of Pharmaceutical Sciences, MANIPAL, India)
  • Abstract:

    Background: Medicines are essential for every human to maintain good health. Hence, it is important to regulate the safety, efficacy and quality of medicines. Most countries in the world have their own regulations for marketing approval of medicines. While patents are meant to reward innovations by giving the inventor monopoly rights for a fixed..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses